Wedbush Initiates Coverage On Tyra Biosciences with Outperform Rating, Announces Price Target of $27
Portfolio Pulse from richadhand@benzinga.com
Wedbush analyst Robert Driscoll has initiated coverage on Tyra Biosciences (NASDAQ:TYRA) with an Outperform rating and a price target of $27.
June 30, 2023 | 8:55 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tyra Biosciences has been given an Outperform rating by Wedbush with a price target of $27.
The Outperform rating from Wedbush indicates a positive outlook for Tyra Biosciences. The price target of $27 suggests that the analyst expects the stock to perform well in the future. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100